The ecg in diabetes mellitus

Circulation

Volumn 120, Issue 16, 2009, Pages 1633-1636

  Stern, Shlomo ^a   Sclarowsky, Samuel ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; GLUCOSE; HEMOGLOBIN A1C; THALLIUM;

ADULT; ANGIOCARDIOGRAPHY; AUTONOMIC NEUROPATHY; BODY MASS; CARDIAC AUTONOMIC NEUROPATHY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CASE REPORT; ELECTROCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEART SCINTISCANNING; HUMAN; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SILENT MYOCARDIAL ISCHEMIA; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD GLUCOSE; CARDIOMYOPATHIES; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FETAL HEART; FOLLOW-UP STUDIES; HEART; HEART CONDUCTION SYSTEM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL ISCHEMIA; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 70350224125     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.897496     Document Type: Review

References (30)

1. Beckman JA, Libby P, Creager MA. Diabetes mellitus, the metabolic syndrome, and atherosclerotic vascular disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa. Saunders Elsevier; 2008: 1094-1105.
2. Laitinen T, Lyyra-Laitinen T, Huopio H, Vauhkonen I, Halonen TP, Hartikainen J, Niskanen L, Laakso M. Electrocardiographic alterations during hyperinsulinemic hypo-glycemia in healthy subjects. Ann Nonin-vasive Electrocardiol. 2008;13:97-105.
3. Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N, Fuller JH, Veglio M, Cavallo-Perrin P. Incidence and risk factors of prolonged QTc interval in type 1 diabetes. The EURODIAB Prospective Complications Study. Diabetes Care. 2007;30:2057-2063.
4. Nelson MB, Daniel KR, Freedman BI, Prineas RJ, Bowden DW, Herrington DM. Associations between electrocardiographic interval durations and coronary artery calcium scores: the Diabetes Heart Study. Pacing Clin Electrophysiol. 2008;31: 314-321.
5. Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV. Electrocardiographic repo-larization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the Strong Heart Study. Diabetes. 2004;53:434-440.
6. Lehtinen AB, Daniel KR, Shah SA, Nelson MR, Ziegler JT, Freedman BI, Carr JJ, Her-rington DM, Langefeld CD, Bowden DW. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics. The diabetes heart study. Ann Noninvasive Electrocardiol. 2009;14:72-79.
7. Sawicki PT, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med. 1998;243:49-56.
8. Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Meisinger C. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population. The MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008;31: 556-561.
9. Giunti S, Bruno G, Veglio M, Gruden G, Webb DJ, Livingstone S, Chaturvedi N, Fuller JH, Perin PC. Electrocardiographic left ventricular hypertrophy in type 1 diabetes. Diabetes Care. 2005;28:2255-2257.
10. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Lindholm LH, Dahlof B. In-treatment resolution or absence of electro-cardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study. Hypertension. 2007;50:984-990.
11. Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH; for the DCCT/EDIC research group. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC). Circulation. 2009;119: 2886-2893.
12. Aronson D, Weinrauch LF, Elia JA, Toller GH, Burger AJ. Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy. Am J Cardiol. 1999;84:449-453.
13. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study, 1987-1998. Circulation. 2003;107:2190-2195.
14. Ong JJ, Sarma JS, Venkataraman K, Levin SR, Singh BN. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J. 1993;125:744-752.
15. Valensi PE, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabetes Care. 2002;25: 918-923.
16. Pappachan JM, Sebastian J, Bino BC, Jayaprakesh K, Sujathan P, Adiengars LA. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J. 2008; 84:205-210.
17. Grossman G, Schwentikowski M, Keck FS, Hoher M, Steinbach G, Osterhues H, Hombach V. Signal-averaged electrocardiogram in patients with insulin-dependent (type 1) diabetes mellitus with and without diabetic neuropathy. Diabetic Med. 2004;14: 364-369.
18. Ewing DJ, Boland O, Neilson JMM, Cho Cg, Clark BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991;34:182-185.
19. Raman M, Nesto RW. Heart disease in diabetes mellitus. Endocrinol Metab Clin North Am. 1996;25:425-438.
20. Dweck M, Campbell IW, Miller D, Francis CM. Clinical aspects of silent myocardial ischemia: with particular reference to diabetes mellitus. Br J Diabetes Vasc Dis. 2009;9:110-116.
21. Wackers FJTh, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE. Detection of silent myocardial ischemia in asymptomatic diabetic subjects. Diabetes Care. 2004;27:1954-1961.
22. Lyerly GW, Sui X, Church TS, Lavie CJ, Hand GA, Blair SN. Maximal exercise elec-trocardiography responses and coronary heart disease mortality among men with diabetes mellitus. Circulation. 2008;117: 2734-2742.
23. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, Mastroianno S, De Cosmo S, Fanelli R, Trischitta V. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol. 2002; 147:649-654.
24. Cosson E, Paycha F, Pares J, Cattan S, Ramadan A, Meddah D, Attali J-R, Valensi P. Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintography. Diabetic Med. 2004;21:342-348.
25. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, Phil-ippides G, Rocchini A. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk. A Scientific Statement from the American Heart Association. Circulation. 2009;119:3244-3262.
26. Yli BM, Kallen K, Stray-Pederson B, Amer-Wahlin I. Intrapartum fetal ECG and diabetes. J Matern Fetal Neonatal Med. 2008;21:231-238.
27. Rollins MD, Jenkins JG, Carson DJ, McClure BG, Mitchell RH, Imam SZ. Power spectral analysis of the electrocardiogram in diabetic children. Diabetologia. 1992;35: 452-455.
28. Shiono J, Horigome H, Kamoda T, Matsui A. Signal-averaged electrocardiogram in children and adolescents with insulin-dependent diabetes mellitus. Acta Paediatr. 2001;90:1244-1248.
29. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type 1 diabetic patients. Diabetes Care. 1994;12:633-639.
30. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular di-astolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98:33-39.